Cardiology
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology
Genetics
Geriatrics/Aging
Hematology/Oncology
Immunology/Allergy
Infectious Disease
Nephrology
Neurology/Neurosurgery
Obstetrics/Gynecology
Pediatrics
Psychiatry
Public Health, Policy, and Training
Pulmonary
Rheumatology
Surgery

Nejm News Une Mise à Jour The New England Journal of Medicine by Specialties

 


The New England Journal of Medicine: Search Results in Dermatology
The New England Journal of Medicine (NEJM) RSS feed -- Search Results in Dermatology. NEJM (http://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.

Strawberry Gingivitis in Granulomatosis with Polyangiitis
01/01/70 - Figure 1.

Molluscum Contagiosum in a Patient with Atopic Dermatitis
01/01/70 - Figure 1.

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
01/01/70 - Ipilimumab (Yervoy, Bristol-Myers Squibb), a human IgG1 monoclonal antibody against cytotoxic T-lymphocyte antigen 4, and nivolumab (Opdivo, Bristol-Myers Squibb), a human IgG4 monoclonal antibody against programmed death 1 (PD-1), are approved for monotherapy and combination therapy in several…

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma
01/01/70 - The incidence of cutaneous melanoma has continued to increase in recent years. For early-stage melanoma, surgical resection is the standard treatment and is associated with an excellent long-term prognosis, with 5-year survival rates of 98% for stage I disease and 90% for stage II disease. However,…

Adjuvant Melanoma Therapy ? Head-Spinning Progress
01/01/70 - Every year in the United States, approximately 87,000 patients receive the diagnosis of melanoma. Although most of these patients are cured with simple excision, those with node-positive, stage III melanoma are at increased risk for distant metastasis and death. To date, the Food and Drug…

Rosacea
01/01/70 - Foreword. This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author?s clinical recommendations. Stage. A 36-year-old…

HIV Infection Manifesting as Proximal White Onychomycosis
01/01/70 - Figure 1.

Pigmented Macule ? A Skin Manifestation of Invasive Breast Cancer
01/01/70 - Figure 1.

Evaluation and Management of Lower-Extremity Ulcers
01/01/70 - Lower-extremity ulcers are very common, with an estimated prevalence of 1 to 2% among U.S. adults, and they have a major effect on public health. Lower-extremity ulcers are divided into two groups ? leg ulcers and foot ulcers ? because of differences in causes, pathogenesis, and treatment. Even…

Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis
01/01/70 - Psoriatic arthritis is a chronic, systemic inflammatory arthritis that occurs in 6 to 42% of patients with psoriasis, affecting the peripheral joints, tendons, ligaments, and the axial skeleton. Current treatment guidelines for psoriatic arthritis recommend conventional synthetic disease-modifying…

Copyright © 2004/2011 Health.Cat

Annuaire de Sante | S'inscrire au MedSante  | Dictionnaire medicale  Forumed des médecins